About-cancer / lapaʻau / lāʻau / esophageal

Ua ʻae ʻia nā lāʻau no ka maʻi ʻaʻai Esophageal

Ua helu ʻia kēia ʻaoʻao i nā lāʻau lapaʻau i ʻāpono ʻia e ka Food and Drug Administration (FDA) no ka maʻi ʻaʻai esophageal, me ka maʻi pūpū gastroesophageal. Loaʻa i ka papa inoa nā inoa generic a me nā inoa inoa. Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau i hoʻohana ʻia i ka maʻi ʻaʻai esophageal i helu ʻole ʻia ma aneʻi.

Ua ʻae ʻia nā lāʻau no ka maʻi ʻaʻai Esophageal

Keytruda (Pembrolizumab)

Pembrolizumab

Hoʻohui ʻia nā hui lāʻau i hoʻohana ʻia i ka maʻi ʻaʻai Esophageal

FU-LV

XELIRI

Ua ʻae ʻia nā lāʻau no Gastroesophageal Junction Cancer

Cyramza (Ramucirumab)

ʻO Docetaxel

Herceptin (Trastuzumab)

Keytruda (Pembrolizumab)

Lonsurf (Trifluridine a me Tipiracil Hydrochloride)

Pembrolizumab

ʻO Ramucirumab

ʻO Taxotere (Docetaxel)

ʻO Trastuzumab

ʻO Trifluridine lāua ʻo Tipiracil Hydrochloride